GlassScriptPhysician profile
Bianca Blackstone
NPI 1043098775
$438.55
in general payments reported to CMS, 2019-2025
11 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $128.92 | 2025 | |
| Madrigal Pharmaceuticals | $122.81 | 2025 | Rezdiffra |
| Qol Medical, LLC | $39.24 | 2025 | Sucraid |
| Celltrion USA INC. | $25.84 | 2025 | Vegzelma |
| Ardelyx, INC. | $24.23 | 2025 | Ibsrela |
| Gilead Sciences, INC. | $19.21 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $18.14 | 2025 | Iqirvo |
| Pfizer INC. | $16.28 | 2025 | |
| Aimmune Therapeutics, INC. | $14.75 | 2025 | Zenpep |
| Ferring Pharmaceuticals INC. | $14.75 | 2025 | Clenpiq |
| Janssen Biotech, INC. | $14.38 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bianca Blackstone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.